[
  {
    "title": "中恒集团(600252.SH)：莱美药业取得醋酸曲普瑞林注射液的药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2023/01/04183037259114.shtml",
    "datetime": "2023-01-04 18:30:54",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：获得醋酸曲普瑞林注射液的药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2023/01/04173937258835.shtml",
    "datetime": "2023-01-04 17:39:07",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：醋酸特利加压素原料药(规格:30g/件)获批上市",
    "href": "http://stock.jrj.com.cn/2022/12/30185637250643.shtml",
    "datetime": "2022-12-30 18:56:23",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：子公司收到2021年产业扶持专项资金5519万元",
    "href": "http://stock.jrj.com.cn/2022/12/29165737246613.shtml",
    "datetime": "2022-12-29 16:57:27",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：前三季度净亏损3737.30万元",
    "href": "http://stock.jrj.com.cn/2022/10/25232837083773.shtml",
    "datetime": "2022-10-25 23:28:12",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：注射用磷酸氟达拉滨通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/09/14175636994658.shtml",
    "datetime": "2022-09-14 17:56:40",
    "code": "300006"
  },
  {
    "title": "莱美药业：注射用磷酸氟达拉滨通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/09/14175136994623.shtml",
    "datetime": "2022-09-14 17:51:26",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：氨甲环酸注射液两种规格通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/08/31172336958631.shtml",
    "datetime": "2022-08-31 17:23:34",
    "code": "300006"
  },
  {
    "title": "中恒集团(600252.SH)：莱美药业的氨甲环酸注射液(5ml：0.25g、5ml：0.5g)通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/08/31171436958564.shtml",
    "datetime": "2022-08-31 17:14:47",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：上半年净亏损4907.17万元 同比盈转亏",
    "href": "http://stock.jrj.com.cn/2022/08/25234836938027.shtml",
    "datetime": "2022-08-25 23:48:04",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：艾司奥美拉唑镁肠溶胶囊获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/08/16170936904700.shtml",
    "datetime": "2022-08-16 17:09:31",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：艾司奥美拉唑镁原料药获得化学原料药上市申请批准通知书",
    "href": "http://stock.jrj.com.cn/2022/08/16170736904715.shtml",
    "datetime": "2022-08-16 17:07:41",
    "code": "300006"
  },
  {
    "title": "双成药业(002693.SZ)：拟将拥有的醋酸曲普瑞林注射液相关权利转让予莱美药业",
    "href": "http://stock.jrj.com.cn/2022/08/01200536860504.shtml",
    "datetime": "2022-08-01 20:05:22",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：拟斥2880万元获得醋酸曲普瑞林注射液相关权益",
    "href": "http://stock.jrj.com.cn/2022/08/01183836860126.shtml",
    "datetime": "2022-08-01 18:38:59",
    "code": "300006"
  },
  {
    "title": "莱美药业：拟签署《醋酸曲普瑞林注射液产品权利转让协议》",
    "href": "http://stock.jrj.com.cn/2022/08/01183036860098.shtml",
    "datetime": "2022-08-01 18:30:35",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：拟终止与友芝友生物的战略合作相关事项",
    "href": "http://stock.jrj.com.cn/2022/07/18193136822314.shtml",
    "datetime": "2022-07-18 19:31:55",
    "code": "300006"
  },
  {
    "title": "莱美药业：终止与友芝友生物的战略合作协议",
    "href": "http://stock.jrj.com.cn/2022/07/18191536822246.shtml",
    "datetime": "2022-07-18 19:15:03",
    "code": "300006"
  },
  {
    "title": "【龙虎榜】莱美药业7月12日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/07/12180236804079.shtml",
    "datetime": "2022-07-12 18:02:50",
    "code": "300006"
  },
  {
    "title": "【龙虎榜】莱美药业7月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/07/11180236799595.shtml",
    "datetime": "2022-07-11 18:02:52",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：邱宇所持1138万股的第二次司法拍卖已流拍",
    "href": "http://stock.jrj.com.cn/2022/06/20211736744321.shtml",
    "datetime": "2022-06-20 21:17:24",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：持股5%以上股东邱宇所持1138万股拟被第二次司法拍卖",
    "href": "http://stock.jrj.com.cn/2022/05/18175236659390.shtml",
    "datetime": "2022-05-18 17:52:30",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：“纳米炭铁混悬注射液”获批药物临床试验",
    "href": "http://stock.jrj.com.cn/2022/05/16185736652346.shtml",
    "datetime": "2022-05-16 18:57:59",
    "code": "300006"
  },
  {
    "title": "莱美药业2022年第一季度亏损2640.35万同比由盈转亏 销售费用下降",
    "href": "http://stock.jrj.com.cn/2022/05/03185036546076.shtml",
    "datetime": "2022-05-03 18:50:48",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)2021年度净亏损1.01亿元 同比减亏69.24%",
    "href": "http://stock.jrj.com.cn/2022/03/27145035560675.shtml",
    "datetime": "2022-03-27 14:50:37",
    "code": "300006"
  },
  {
    "title": "莱美药业2021年亏损1.01亿同比亏损减少 总经理邱戎钊薪酬51.06万",
    "href": "http://stock.jrj.com.cn/2022/03/26051235220888.shtml",
    "datetime": "2022-03-26 05:12:53",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：邱宇所持1.08%股份将被司法拍卖",
    "href": "http://stock.jrj.com.cn/2022/03/18175234846109.shtml",
    "datetime": "2022-03-18 17:52:12",
    "code": "300006"
  },
  {
    "title": "中恒集团(600252.SH)：莱美药业注射用甲泼尼龙琥珀酸钠通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/02/22181834435388.shtml",
    "datetime": "2022-02-22 18:18:59",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：注射用甲泼尼龙琥珀酸钠(40mg)通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/02/22173534435125.shtml",
    "datetime": "2022-02-22 17:35:34",
    "code": "300006"
  },
  {
    "title": "莱美药业2021年预计亏损8500万-1.08亿 较上年同期亏损减少",
    "href": "http://stock.jrj.com.cn/2022/01/29091034254164.shtml",
    "datetime": "2022-01-29 09:10:51",
    "code": "300006"
  },
  {
    "title": "莱美药业：预计2021年全年净利润同比减亏66.95％至73.99％",
    "href": "http://stock.jrj.com.cn/2022/01/28220934251094.shtml",
    "datetime": "2022-01-28 22:09:26",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：选举梁建生为第五届董事会董事长",
    "href": "http://stock.jrj.com.cn/2021/12/30203234088204.shtml",
    "datetime": "2021-12-30 20:32:46",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：胞磷胆碱钠氯化钠注射液新纳入医保目录",
    "href": "http://stock.jrj.com.cn/2021/12/07180433980870.shtml",
    "datetime": "2021-12-07 18:04:12",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：西藏莱美所持2000万股已办理完成司法过户登记手续",
    "href": "http://stock.jrj.com.cn/2021/12/02204333956808.shtml",
    "datetime": "2021-12-02 20:43:12",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：西藏莱美被司法拍卖的2000万股 由张寿春成功竞得",
    "href": "http://stock.jrj.com.cn/2021/11/22215033905745.shtml",
    "datetime": "2021-11-22 21:50:13",
    "code": "300006"
  },
  {
    "title": "药明康德、莱美药业等上市公司争抢PROTAC等靶向降解市场 相关开发企业屡获融资",
    "href": "http://stock.jrj.com.cn/2021/11/20194733887393.shtml",
    "datetime": "2021-11-20 19:47:14",
    "code": "300006"
  },
  {
    "title": "莱美药业稀释成都金星控股权 业务结构梳理已近尾声",
    "href": "http://stock.jrj.com.cn/2021/11/17212633868032.shtml",
    "datetime": "2021-11-17 21:26:28",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：成都金星拟获耀匀医药增资约1.128亿元",
    "href": "http://stock.jrj.com.cn/2021/11/15220633856327.shtml",
    "datetime": "2021-11-15 22:06:06",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：三唑类抗真菌药伏立康唑片获批上市",
    "href": "http://stock.jrj.com.cn/2021/11/08175733823828.shtml",
    "datetime": "2021-11-08 17:57:06",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：西藏莱美所持2000万股将被第二次司法拍卖",
    "href": "http://stock.jrj.com.cn/2021/11/03192133809418.shtml",
    "datetime": "2021-11-03 19:21:41",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：联营企业与AglaeaPharma签署项目合作开发协议",
    "href": "http://stock.jrj.com.cn/2021/10/24202333740150.shtml",
    "datetime": "2021-10-24 20:23:41",
    "code": "300006"
  },
  {
    "title": "莱美药业：联营企业阿格莱雅与AglaeaPharma共同委托CRO公司开展药物开发工作",
    "href": "http://stock.jrj.com.cn/2021/10/24173833739804.shtml",
    "datetime": "2021-10-24 17:38:45",
    "code": "300006"
  },
  {
    "title": "【龙虎榜】莱美药业10月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/10/18180233711828.shtml",
    "datetime": "2021-10-18 18:02:02",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：拟收购奥信阳光的丁苯酞注射液产品 涉及两个规格",
    "href": "http://stock.jrj.com.cn/2021/09/13180933429280.shtml",
    "datetime": "2021-09-13 18:09:06",
    "code": "300006"
  },
  {
    "title": "莱美药业2名股东合计将被动减持9906.54万股 上半年公司净利3239.27万",
    "href": "http://stock.jrj.com.cn/2021/09/09212433411472.shtml",
    "datetime": "2021-09-09 21:24:51",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：股东邱宇及其一致行动人所持9906.54万股将被司法拍卖",
    "href": "http://stock.jrj.com.cn/2021/09/09194533410888.shtml",
    "datetime": "2021-09-09 19:45:37",
    "code": "300006"
  },
  {
    "title": "【龙虎榜】莱美药业8月6日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/08/06180333213670.shtml",
    "datetime": "2021-08-06 18:03:35",
    "code": "300006"
  },
  {
    "title": "A股异动丨莱美药业(300006.SZ)大涨18.47% 拟230万美元入股Replicor 布局乙肝药物赛道发力肝病领域",
    "href": "http://stock.jrj.com.cn/2021/08/06110533211707.shtml",
    "datetime": "2021-08-06 11:05:00",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：莱美香港拟以299万美元认购Replicor股份23万股",
    "href": "http://stock.jrj.com.cn/2021/08/05200233208773.shtml",
    "datetime": "2021-08-05 20:02:24",
    "code": "300006"
  },
  {
    "title": "莱美药业2021年上半年净利3239.27万 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/07/30235033177591.shtml",
    "datetime": "2021-07-30 23:50:57",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：上半年净利3239.27万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/07/30192333176605.shtml",
    "datetime": "2021-07-30 19:23:22",
    "code": "300006"
  },
  {
    "title": "莱美药业：公司发起设立的AglaeaPharma中国药物有限公司目前正在设立过程中",
    "href": "http://stock.jrj.com.cn/2021/05/31162032850208.shtml",
    "datetime": "2021-05-31 16:20:07",
    "code": "300006"
  },
  {
    "title": "莱美药业：目前公司子公司爱甲专线已与一些医疗美容机构建立合作关系 主要为患者提供疤痕修复相关服务",
    "href": "http://stock.jrj.com.cn/2021/05/31160832850102.shtml",
    "datetime": "2021-05-31 16:08:33",
    "code": "300006"
  },
  {
    "title": "莱美药业：目前公司产品纳米碳混悬注射液仅在国内进行销售 暂无进入国际市场的计划",
    "href": "http://stock.jrj.com.cn/2021/05/31160332850063.shtml",
    "datetime": "2021-05-31 16:03:42",
    "code": "300006"
  },
  {
    "title": "中恒集团：公司支持莱美药业聚焦优势细分领域 加速销售模式转型",
    "href": "http://stock.jrj.com.cn/2021/04/26133232453385.shtml",
    "datetime": "2021-04-26 13:32:10",
    "code": "300006"
  },
  {
    "title": "莱美药业2021年第一季度净利4890.63万 转让部分子公司股权取得投资收益",
    "href": "http://stock.jrj.com.cn/2021/04/24204032435866.shtml",
    "datetime": "2021-04-24 20:40:01",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)一季度净利达4890.63万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/04/24113732434919.shtml",
    "datetime": "2021-04-24 11:37:17",
    "code": "300006"
  },
  {
    "title": "莱美药业：目前阿托品滴眼液已上市销售",
    "href": "http://stock.jrj.com.cn/2021/04/14191732373165.shtml",
    "datetime": "2021-04-14 19:17:53",
    "code": "300006"
  },
  {
    "title": "莱美药业2021年第一季度预计净利4500万-5000万 业务恢复、收入增长",
    "href": "http://stock.jrj.com.cn/2021/03/31233032259155.shtml",
    "datetime": "2021-03-31 23:30:30",
    "code": "300006"
  },
  {
    "title": "莱美药业2020年亏损3.27亿 药品销量下滑",
    "href": "http://stock.jrj.com.cn/2021/03/31223032258819.shtml",
    "datetime": "2021-03-31 22:30:53",
    "code": "300006"
  },
  {
    "title": "莱美药业：公司股东邱宇先生所持公司股票全部处于质押和司法冻结状态",
    "href": "http://stock.jrj.com.cn/2021/03/31170732256795.shtml",
    "datetime": "2021-03-31 17:07:55",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)一季度扭亏为盈 预盈4500万元-5000万元",
    "href": "http://stock.jrj.com.cn/2021/03/30232432250917.shtml",
    "datetime": "2021-03-30 23:24:43",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)2020年净亏扩至3.27亿元",
    "href": "http://stock.jrj.com.cn/2021/03/30232232250909.shtml",
    "datetime": "2021-03-30 23:22:03",
    "code": "300006"
  },
  {
    "title": "莱美药业原董事长收监管函 被动减持信披违规",
    "href": "http://stock.jrj.com.cn/2021/03/24170632209294.shtml",
    "datetime": "2021-03-24 17:06:00",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：股东邱宇及其一致行动人持股比例被动稀释超5%及所持15.72万股遭被动减持",
    "href": "http://stock.jrj.com.cn/2021/03/18181732158445.shtml",
    "datetime": "2021-03-18 18:17:09",
    "code": "300006"
  },
  {
    "title": "中恒集团并购莱美药业两年亏4.2亿 销售费占近半营收超研发费32倍",
    "href": "http://stock.jrj.com.cn/2021/03/15071532134474.shtml",
    "datetime": "2021-03-15 07:15:56",
    "code": "300006"
  },
  {
    "title": "莱美药业拟投资5000万元设立合资公司 提升公司在医药行业的核心竞争力",
    "href": "http://stock.jrj.com.cn/2021/03/11220332111215.shtml",
    "datetime": "2021-03-11 22:03:27",
    "code": "300006"
  },
  {
    "title": "中恒集团(600252.SH)：莱美药业拟转让成都美康35%股权及四川美康2.25%股权",
    "href": "http://stock.jrj.com.cn/2021/03/11202832110888.shtml",
    "datetime": "2021-03-11 20:28:04",
    "code": "300006"
  },
  {
    "title": "中恒集团(600252.SH)：莱美药业拟转让禾正制药100%股权",
    "href": "http://stock.jrj.com.cn/2021/03/11202432110882.shtml",
    "datetime": "2021-03-11 20:24:09",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)拟共同设立Aglaea Pharma中国药物有限公司",
    "href": "http://stock.jrj.com.cn/2021/03/11200732110817.shtml",
    "datetime": "2021-03-11 20:07:43",
    "code": "300006"
  },
  {
    "title": "中恒集团(600252.SH)拟变更7.32亿元募集资金用途 用于拟认购莱美药业股份",
    "href": "http://stock.jrj.com.cn/2021/02/22175732006915.shtml",
    "datetime": "2021-02-22 17:57:50",
    "code": "300006"
  },
  {
    "title": "莱美药业战略调整打造细分龙头 10亿定增获批国资持股比将超30%",
    "href": "http://stock.jrj.com.cn/2021/02/19081031990594.shtml",
    "datetime": "2021-02-19 08:10:51",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：定增申请获证监会同意注册批复",
    "href": "http://stock.jrj.com.cn/2021/02/09210531879303.shtml",
    "datetime": "2021-02-09 21:05:18",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)拟受让爱甲专线部分股权并对核心管理团队进行股权激励",
    "href": "http://stock.jrj.com.cn/2021/02/08202231872040.shtml",
    "datetime": "2021-02-08 20:22:02",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)拟1.65亿元转让禾正制药100%股权予布莱森",
    "href": "http://stock.jrj.com.cn/2021/02/08201731872009.shtml",
    "datetime": "2021-02-08 20:17:53",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：拟转让成都美康35%股权及四川美康2.25%股权",
    "href": "http://stock.jrj.com.cn/2021/02/08201631872006.shtml",
    "datetime": "2021-02-08 20:16:16",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：拟由艾丁格尔对湖南康源实施整体承包经营",
    "href": "http://stock.jrj.com.cn/2021/02/08201431871995.shtml",
    "datetime": "2021-02-08 20:14:20",
    "code": "300006"
  },
  {
    "title": "莱美药业2020年预计亏损2.7亿-3.3亿 市场需求量下降",
    "href": "http://stock.jrj.com.cn/2021/01/30205431815587.shtml",
    "datetime": "2021-01-30 20:54:22",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)拟0元转让莱美健康60%股权予智赢优远",
    "href": "http://stock.jrj.com.cn/2021/01/15202731701210.shtml",
    "datetime": "2021-01-15 20:27:08",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)拟1200万元转让莱美金鼠70%股权",
    "href": "http://stock.jrj.com.cn/2021/01/15202531701200.shtml",
    "datetime": "2021-01-15 20:25:10",
    "code": "300006"
  },
  {
    "title": "中恒集团(600252.SH)：对莱美药业提供的1.1亿元财务资助展期",
    "href": "http://stock.jrj.com.cn/2021/01/07171831648715.shtml",
    "datetime": "2021-01-07 17:18:45",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：注射用艾司奥美拉唑钠和注射用甲泼尼龙琥珀酸钠两个产品被纳入医保目录",
    "href": "http://stock.jrj.com.cn/2020/12/29193431597040.shtml",
    "datetime": "2020-12-29 19:34:19",
    "code": "300006"
  },
  {
    "title": "[莱美药业]广投集团、中恒领导组莅临我司指导工作",
    "href": "http://stock.jrj.com.cn/2020/12/29000031596526.shtml",
    "datetime": "2020-12-29 00:00:00",
    "code": "300006"
  },
  {
    "title": "[莱美药业]中恒集团领导组莅临我司指导工作",
    "href": "http://stock.jrj.com.cn/2020/12/27000031586047.shtml",
    "datetime": "2020-12-27 00:00:00",
    "code": "300006"
  },
  {
    "title": "莱美药业：目前公司子公司四川瀛瑞医药科技有限公司正按研发计划开展纳米炭铁项目临床前研究工作",
    "href": "http://stock.jrj.com.cn/2020/12/22152431545276.shtml",
    "datetime": "2020-12-22 15:24:47",
    "code": "300006"
  },
  {
    "title": "中恒集团(600252.SH)：莱美药业取得艾司奥美拉唑钠药品注册证书",
    "href": "http://stock.jrj.com.cn/2020/12/08182831441737.shtml",
    "datetime": "2020-12-08 18:28:55",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：取得注射用艾司奥美拉唑钠的药品注册证书",
    "href": "http://stock.jrj.com.cn/2020/12/08172631441192.shtml",
    "datetime": "2020-12-08 17:26:52",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：定增申请获深交所审核通过",
    "href": "http://stock.jrj.com.cn/2020/11/12083131265329.shtml",
    "datetime": "2020-11-12 08:31:02",
    "code": "300006"
  },
  {
    "title": "莱美药业：广州赛富健康产业投资合伙企业（有限合伙）拥有其权益比例为10%",
    "href": "http://stock.jrj.com.cn/2020/11/10160531251390.shtml",
    "datetime": "2020-11-10 16:05:49",
    "code": "300006"
  },
  {
    "title": "[莱美药业]中恒集团领导莅临我司考察指导",
    "href": "http://stock.jrj.com.cn/2020/11/05000031220342.shtml",
    "datetime": "2020-11-05 00:00:00",
    "code": "300006"
  },
  {
    "title": "莱美药业2020年前三季度净利54.48万下滑99.28% 应收账款减少",
    "href": "http://stock.jrj.com.cn/2020/10/28142931150636.shtml",
    "datetime": "2020-10-28 14:29:03",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：前三季度净利降99.28%至54.48万元",
    "href": "http://stock.jrj.com.cn/2020/10/27211531144495.shtml",
    "datetime": "2020-10-27 21:15:49",
    "code": "300006"
  },
  {
    "title": "莱美药业(300006.SZ)：认购对象出具不减持公司股份承诺函",
    "href": "http://stock.jrj.com.cn/2020/10/20215231094836.shtml",
    "datetime": "2020-10-20 21:52:24",
    "code": "300006"
  },
  {
    "title": "[互动]莱美药业：公司拥有注射用地塞米松磷酸钠相关产品",
    "href": "http://stock.jrj.com.cn/2020/10/19145231083254.shtml",
    "datetime": "2020-10-19 14:52:27",
    "code": "300006"
  },
  {
    "title": "[莱美药业]热烈祝贺莱美荣获2020中国化药制药行业多项优秀产品品牌",
    "href": "http://stock.jrj.com.cn/2020/10/14000031053234.shtml",
    "datetime": "2020-10-14 00:00:00",
    "code": "300006"
  },
  {
    "title": "中恒集团(600252.SH)：莱美药业拟参投合伙企业 其直接投资友芝友生物",
    "href": "http://stock.jrj.com.cn/2020/09/21221630804972.shtml",
    "datetime": "2020-09-21 22:16:25",
    "code": "300006"
  },
  {
    "title": "[莱美药业]公司党支部就中信“党费通”开展交流学习活动",
    "href": "http://stock.jrj.com.cn/2020/09/15000030758153.shtml",
    "datetime": "2020-09-15 00:00:00",
    "code": "300006"
  },
  {
    "title": "莱美药业：与友芝友生物签订战略合作协议 并获得眼科类用药Y400双抗药物相关权益",
    "href": "http://stock.jrj.com.cn/2020/09/14222330750133.shtml",
    "datetime": "2020-09-14 22:23:13",
    "code": "300006"
  },
  {
    "title": "爱尔眼科：与莱美药业合作开发儿童青少年近视及干眼症等一系列眼科药品及护理产品",
    "href": "http://stock.jrj.com.cn/2020/09/14215930750038.shtml",
    "datetime": "2020-09-14 21:59:34",
    "code": "300006"
  },
  {
    "title": "莱美药业2020年上半年亏损810.34万由盈转亏 医院患者流量减少",
    "href": "http://stock.jrj.com.cn/2020/08/30153130622651.shtml",
    "datetime": "2020-08-30 15:31:43",
    "code": "300006"
  },
  {
    "title": "莱美药业获3300余万元政府补助",
    "href": "http://stock.jrj.com.cn/2020/08/19231230541786.shtml",
    "datetime": "2020-08-19 23:12:22",
    "code": "300006"
  },
  {
    "title": "【龙虎榜】莱美药业8月4日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/08/04180230425026.shtml",
    "datetime": "2020-08-04 18:02:53",
    "code": "300006"
  },
  {
    "title": "中恒集团、莱美药业携手挺进中国医药工业百强榜 深度合作书写创新医药产业新篇章",
    "href": "http://stock.jrj.com.cn/2020/07/26173930341559.shtml",
    "datetime": "2020-07-26 17:39:42",
    "code": "300006"
  },
  {
    "title": "中恒集团、莱美药业携手挺进中国医药工业百强榜 深度合作书写创新医药产业新篇章",
    "href": "http://stock.jrj.com.cn/2020/07/23093930320992.shtml",
    "datetime": "2020-07-23 09:39:52",
    "code": "300006"
  },
  {
    "title": "莱美药业小幅修订定增计划",
    "href": "http://stock.jrj.com.cn/2020/07/03222730137013.shtml",
    "datetime": "2020-07-03 22:27:56",
    "code": "300006"
  },
  {
    "title": "莱美药业：2019年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2020/06/24223030012874.shtml",
    "datetime": "2020-06-24 22:30:00",
    "code": "300006"
  },
  {
    "title": "莱美药业完成董事会换届选举 中恒医药集群版图再扩",
    "href": "http://stock.jrj.com.cn/2020/06/23141129998645.shtml",
    "datetime": "2020-06-23 14:11:00",
    "code": "300006"
  },
  {
    "title": "莱美药业顺利换届 携手保险创新甲状腺健康管理模式",
    "href": "http://stock.jrj.com.cn/2020/06/12224529911715.shtml",
    "datetime": "2020-06-12 22:45:00",
    "code": "300006"
  },
  {
    "title": "莱美药业：完成换届选举 子公司与信美保险社签订框架协议",
    "href": "http://stock.jrj.com.cn/2020/06/12222429911657.shtml",
    "datetime": "2020-06-12 22:24:00",
    "code": "300006"
  },
  {
    "title": "实控人790万股被强制拍卖 公司资产抛售未果 莱美药业自救难",
    "href": "http://stock.jrj.com.cn/2020/06/10073429886819.shtml",
    "datetime": "2020-06-10 07:34:00",
    "code": "300006"
  },
  {
    "title": "莱美药业股东邱炜所持2147万股公司股份司法拍卖流拍",
    "href": "http://stock.jrj.com.cn/2020/06/01222129818216.shtml",
    "datetime": "2020-06-01 22:21:52",
    "code": "300006"
  },
  {
    "title": "[中恒集团]集团领导率队调研重庆莱美药业",
    "href": "http://stock.jrj.com.cn/2020/05/11000029642401.shtml",
    "datetime": "2020-05-11 00:00:00",
    "code": "300006"
  },
  {
    "title": "莱美药业2019年亏损1.55亿 较上年同期由盈转亏",
    "href": "http://stock.jrj.com.cn/2020/04/26222829379361.shtml",
    "datetime": "2020-04-26 22:28:44",
    "code": "300006"
  },
  {
    "title": "莱美药业2020年第一季度亏损811.97万元 药品终端市场需求减少",
    "href": "http://stock.jrj.com.cn/2020/04/26212029378858.shtml",
    "datetime": "2020-04-26 21:20:16",
    "code": "300006"
  },
  {
    "title": "莱美药业：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/10085029253966.shtml",
    "datetime": "2020-04-10 08:50:03",
    "code": "300006"
  },
  {
    "title": "莱美药业2020年第一季度预计亏损700万元–800万元 原材料采购受到一定程度限制",
    "href": "http://stock.jrj.com.cn/2020/04/10072429253191.shtml",
    "datetime": "2020-04-10 07:24:48",
    "code": "300006"
  },
  {
    "title": "莱美药业：实控人变更为广西国资委",
    "href": "http://stock.jrj.com.cn/2020/04/08201329239251.shtml",
    "datetime": "2020-04-08 20:13:00",
    "code": "300006"
  },
  {
    "title": "莱美药业股东邱炜2360万股股份拟被司法拍卖",
    "href": "http://stock.jrj.com.cn/2020/03/23213029085868.shtml",
    "datetime": "2020-03-23 21:30:24",
    "code": "300006"
  },
  {
    "title": "莱美药业：拟终止设立知识产权基金",
    "href": "http://stock.jrj.com.cn/2020/03/17181329046228.shtml",
    "datetime": "2020-03-17 18:13:00",
    "code": "300006"
  },
  {
    "title": "莱美药业：拟非公开发行募资不超10.97亿元",
    "href": "http://stock.jrj.com.cn/2020/03/08211728974404.shtml",
    "datetime": "2020-03-08 21:17:00",
    "code": "300006"
  },
  {
    "title": "莱美药业：拟定增募资不超10.96亿 中恒集团等参与认购",
    "href": "http://stock.jrj.com.cn/2020/03/08195128974206.shtml",
    "datetime": "2020-03-08 19:51:31",
    "code": "300006"
  },
  {
    "title": "中恒集团：拟不超9.5亿元认购莱美药业定增股份",
    "href": "http://stock.jrj.com.cn/2020/03/08191428974157.shtml",
    "datetime": "2020-03-08 19:14:00",
    "code": "300006"
  },
  {
    "title": "中恒集团 ：拟9.5亿元认购莱美药业定增股份",
    "href": "http://stock.jrj.com.cn/2020/03/08174228973999.shtml",
    "datetime": "2020-03-08 17:42:00",
    "code": "300006"
  },
  {
    "title": "中恒集团：拟参与认购莱美药业定增股份 认购金额不超9.5亿",
    "href": "http://stock.jrj.com.cn/2020/03/08173828973993.shtml",
    "datetime": "2020-03-08 17:38:11",
    "code": "300006"
  },
  {
    "title": "莱美药业2019年亏损1.62亿元 公司终止经济性差的在研项目",
    "href": "http://stock.jrj.com.cn/2020/02/28233928918028.shtml",
    "datetime": "2020-02-28 23:39:35",
    "code": "300006"
  },
  {
    "title": "莱美药业：筹划非公开发行股票事项",
    "href": "http://stock.jrj.com.cn/2020/02/20204428864345.shtml",
    "datetime": "2020-02-20 20:44:36",
    "code": "300006"
  },
  {
    "title": "莱美药业正筹划非公开发行股票事宜 拟发行不超过2.44亿股",
    "href": "http://stock.jrj.com.cn/2020/02/20204128864344.shtml",
    "datetime": "2020-02-20 20:41:00",
    "code": "300006"
  },
  {
    "title": "莱美药业：筹划非公开发行股票",
    "href": "http://stock.jrj.com.cn/2020/02/20195728864119.shtml",
    "datetime": "2020-02-20 19:57:00",
    "code": "300006"
  },
  {
    "title": "资产甩卖按下“暂停键” 莱美药业股东计划期满未减持",
    "href": "http://stock.jrj.com.cn/2020/02/18073328845611.shtml",
    "datetime": "2020-02-18 07:33:48",
    "code": "300006"
  },
  {
    "title": "莱美药业拟剥离5家子公司股权 聚焦优势细分领域",
    "href": "http://stock.jrj.com.cn/2020/02/11212228811426.shtml",
    "datetime": "2020-02-11 21:22:28",
    "code": "300006"
  },
  {
    "title": "莱美药业捐赠200万元药品支援疫情防控",
    "href": "http://stock.jrj.com.cn/2020/02/02150228748494.shtml",
    "datetime": "2020-02-02 15:02:00",
    "code": "300006"
  },
  {
    "title": "[莱美药业]共同抗击新型冠状病毒,莱美在行动!",
    "href": "http://stock.jrj.com.cn/2020/02/02000028750301.shtml",
    "datetime": "2020-02-02 00:00:00",
    "code": "300006"
  },
  {
    "title": "莱美药业：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/23205028729133.shtml",
    "datetime": "2020-01-23 20:50:00",
    "code": "300006"
  },
  {
    "title": "莱美药业2019年度预计亏损1.75亿元–1.8亿元 同比减少278.57%-283.67%",
    "href": "http://stock.jrj.com.cn/2020/01/23201528729017.shtml",
    "datetime": "2020-01-23 20:15:06",
    "code": "300006"
  },
  {
    "title": "莱美药业控制权易主广西国资",
    "href": "http://stock.jrj.com.cn/2020/01/21224228715588.shtml",
    "datetime": "2020-01-21 22:42:11",
    "code": "300006"
  },
  {
    "title": "莱美药业实控人拟委托22.7%表决权 中恒集团还将计划增持13.5亿元",
    "href": "http://stock.jrj.com.cn/2020/01/03095528622922.shtml",
    "datetime": "2020-01-03 09:55:00",
    "code": "300006"
  },
  {
    "title": "实控人变国资 莱美药业实控人将表决权委托给中恒集团",
    "href": "http://stock.jrj.com.cn/2020/01/03073028622339.shtml",
    "datetime": "2020-01-03 07:30:48",
    "code": "300006"
  },
  {
    "title": "莱美药业实控人拟委托表决权 中恒集团有望入主",
    "href": "http://stock.jrj.com.cn/2020/01/02232828619883.shtml",
    "datetime": "2020-01-02 23:28:19",
    "code": "300006"
  },
  {
    "title": "莱美药业实控人拟委托表决权 中恒集团增持金额再增10亿",
    "href": "http://stock.jrj.com.cn/2020/01/02221228619613.shtml",
    "datetime": "2020-01-02 22:12:59",
    "code": "300006"
  },
  {
    "title": "莱美药业：中恒集团将成为公司单一拥有表决权份额最大的股东",
    "href": "http://stock.jrj.com.cn/2020/01/02194628619101.shtml",
    "datetime": "2020-01-02 19:46:00",
    "code": "300006"
  },
  {
    "title": "中恒集团拟以自有资金向莱美药业提供8000万元的财务资助",
    "href": "http://stock.jrj.com.cn/2019/12/31224028612625.shtml",
    "datetime": "2019-12-31 22:40:35",
    "code": "300006"
  },
  {
    "title": "莱美药业拟接受中恒集团向公司提供的财务资助 预计资助金额8000万元",
    "href": "http://stock.jrj.com.cn/2019/12/31223828612598.shtml",
    "datetime": "2019-12-31 22:38:48",
    "code": "300006"
  },
  {
    "title": "输血+增持 莱美药业获中恒集团战略支持",
    "href": "http://stock.jrj.com.cn/2019/12/31222928612581.shtml",
    "datetime": "2019-12-31 22:29:41",
    "code": "300006"
  },
  {
    "title": "莱美药业拟接受中恒集团8000万财务资助 利率为5.5%",
    "href": "http://stock.jrj.com.cn/2019/12/31175928611595.shtml",
    "datetime": "2019-12-31 17:59:54",
    "code": "300006"
  },
  {
    "title": "莱美药业拟接受中恒集团8000万元财务资助",
    "href": "http://stock.jrj.com.cn/2019/12/31173628611557.shtml",
    "datetime": "2019-12-31 17:36:34",
    "code": "300006"
  },
  {
    "title": "莱美药业：拟接受中恒集团8000万元财务资助",
    "href": "http://stock.jrj.com.cn/2019/12/31171628611014.shtml",
    "datetime": "2019-12-31 17:16:18",
    "code": "300006"
  },
  {
    "title": "公告精选：中恒集团拟增持莱美药业股票；富祥股份2019年净利大幅预增",
    "href": "http://stock.jrj.com.cn/2019/12/29200328600035.shtml",
    "datetime": "2019-12-29 20:03:00",
    "code": "300006"
  },
  {
    "title": "公告精选：中恒集团拟增持莱美药业股票；坚瑞沃能重整计划获批准",
    "href": "http://stock.jrj.com.cn/2019/12/29200128600031.shtml",
    "datetime": "2019-12-29 20:01:00",
    "code": "300006"
  },
  {
    "title": "中恒集团拟举牌莱美药业 剑指控股权",
    "href": "http://stock.jrj.com.cn/2019/12/29174128599846.shtml",
    "datetime": "2019-12-29 17:41:00",
    "code": "300006"
  },
  {
    "title": "中恒集团拟以3000万-3.5亿元增持莱美药业",
    "href": "http://stock.jrj.com.cn/2019/12/29155828599697.shtml",
    "datetime": "2019-12-29 15:58:09",
    "code": "300006"
  },
  {
    "title": "中恒集团：拟以3000万-3.5亿元增持莱美药业",
    "href": "http://stock.jrj.com.cn/2019/12/29144828599626.shtml",
    "datetime": "2019-12-29 14:48:00",
    "code": "300006"
  },
  {
    "title": "[哈药股份]中恒集团30亿入驻莱美药业,拉开并购大幕",
    "href": "http://stock.jrj.com.cn/2019/11/27000028459445.shtml",
    "datetime": "2019-11-27 00:00:00",
    "code": "300006"
  },
  {
    "title": "奔走在卖壳的道路上 莱美药业控股股东再寻买家",
    "href": "http://stock.jrj.com.cn/2019/11/25191828448799.shtml",
    "datetime": "2019-11-25 19:18:34",
    "code": "300006"
  },
  {
    "title": "莱美药业控股股东与南岸城建终止《战略合作意向协议》暨新签订《战略合作框架协议》",
    "href": "http://stock.jrj.com.cn/2019/11/25130328446886.shtml",
    "datetime": "2019-11-25 13:03:12",
    "code": "300006"
  },
  {
    "title": "中恒集团与莱美药业、邱宇签订战略合作框架协议",
    "href": "http://stock.jrj.com.cn/2019/11/25130228446884.shtml",
    "datetime": "2019-11-25 13:02:38",
    "code": "300006"
  },
  {
    "title": "莱美药业：拟引入国资战投中恒集团 实控人或变更",
    "href": "http://stock.jrj.com.cn/2019/11/25082928445378.shtml",
    "datetime": "2019-11-25 08:29:00",
    "code": "300006"
  },
  {
    "title": "莱美药业获得《药品GMP证书》",
    "href": "http://stock.jrj.com.cn/2019/10/31085928331076.shtml",
    "datetime": "2019-10-31 08:59:55",
    "code": "300006"
  },
  {
    "title": "莱美药业获药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/10/29205328320240.shtml",
    "datetime": "2019-10-29 20:53:36",
    "code": "300006"
  },
  {
    "title": "莱美药业第三季度盈利2218元万 同比增长15%",
    "href": "http://stock.jrj.com.cn/2019/10/28090428308118.shtml",
    "datetime": "2019-10-28 09:04:22",
    "code": "300006"
  },
  {
    "title": "莱美药业及其全资及控股子公司今年获得政府补助共计2634万元",
    "href": "http://stock.jrj.com.cn/2019/10/27210028305802.shtml",
    "datetime": "2019-10-27 21:00:16",
    "code": "300006"
  },
  {
    "title": "莱美药业2019年前三季度净利7500万-8000万 业绩的稳定增长",
    "href": "http://stock.jrj.com.cn/2019/10/15132128249425.shtml",
    "datetime": "2019-10-15 13:21:45",
    "code": "300006"
  },
  {
    "title": "莱美药业：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/15093028247885.shtml",
    "datetime": "2019-10-15 09:30:00",
    "code": "300006"
  },
  {
    "title": "[莱美药业]莱美药业荣获“国家技术创新示范企业”称号",
    "href": "http://stock.jrj.com.cn/2019/10/11000028239915.shtml",
    "datetime": "2019-10-11 00:00:00",
    "code": "300006"
  },
  {
    "title": "[莱美药业]莱美荣获新中国成立70周年医药产业优秀企业光荣榜--标杆企业",
    "href": "http://stock.jrj.com.cn/2019/10/11000028234261.shtml",
    "datetime": "2019-10-11 00:00:00",
    "code": "300006"
  },
  {
    "title": "[莱美药业]莱美荣获2019中国化药制药行业百强企业等多项大奖",
    "href": "http://stock.jrj.com.cn/2019/10/11000028234264.shtml",
    "datetime": "2019-10-11 00:00:00",
    "code": "300006"
  },
  {
    "title": "莱美药业股东邱炜拟减持股份 预计减持不超总股本1%",
    "href": "http://stock.jrj.com.cn/2019/10/10212828228885.shtml",
    "datetime": "2019-10-10 21:28:13",
    "code": "300006"
  },
  {
    "title": "莱美药业2名股东拟减持股份 预计合计减持不超总股本0.06%",
    "href": "http://stock.jrj.com.cn/2019/09/05074028092036.shtml",
    "datetime": "2019-09-05 07:40:08",
    "code": "300006"
  },
  {
    "title": "莱美药业上半年特色专科药品增长较快",
    "href": "http://stock.jrj.com.cn/2019/08/29225528058274.shtml",
    "datetime": "2019-08-29 22:55:10",
    "code": "300006"
  },
  {
    "title": "莱美药业2019年上半年净利5387万 特色专科类产品增速较快",
    "href": "http://stock.jrj.com.cn/2019/08/29210028057766.shtml",
    "datetime": "2019-08-29 21:00:33",
    "code": "300006"
  },
  {
    "title": "莱美药业两品种新纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/08/26212528035779.shtml",
    "datetime": "2019-08-26 21:25:38",
    "code": "300006"
  },
  {
    "title": "刚迎纾困基金的莱美药业又遇救兵 同行拟出资不超2亿入股",
    "href": "http://stock.jrj.com.cn/2019/07/15231927847902.shtml",
    "datetime": "2019-07-15 23:19:47",
    "code": "300006"
  },
  {
    "title": "莱美药业：百年壹号及岳巍拟不超2亿元入股",
    "href": "http://stock.jrj.com.cn/2019/07/15214727843824.shtml",
    "datetime": "2019-07-15 21:47:09",
    "code": "300006"
  },
  {
    "title": "莱美药业再搬“救兵” 益佰制药前高管承诺出资入股不超2亿元",
    "href": "http://stock.jrj.com.cn/2019/07/15213827844324.shtml",
    "datetime": "2019-07-15 21:38:00",
    "code": "300006"
  },
  {
    "title": "莱美药业签订合作备忘录 百年壹号成潜在股东",
    "href": "http://stock.jrj.com.cn/2019/07/15212827845770.shtml",
    "datetime": "2019-07-15 21:28:24",
    "code": "300006"
  },
  {
    "title": "莱美药业：百年壹号及岳巍拟不超2亿元入股",
    "href": "http://stock.jrj.com.cn/2019/07/15190427843203.shtml",
    "datetime": "2019-07-15 19:04:50",
    "code": "300006"
  },
  {
    "title": "莱美药业2019年上半年净利5600万至6100万 重点产品销售增长",
    "href": "http://stock.jrj.com.cn/2019/07/13092327836195.shtml",
    "datetime": "2019-07-13 09:23:33",
    "code": "300006"
  },
  {
    "title": "莱美药业：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/07/13010027834864.shtml",
    "datetime": "2019-07-13 01:00:00",
    "code": "300006"
  },
  {
    "title": "重点产品销售增长 莱美药业上半年扣非后净利预增",
    "href": "http://stock.jrj.com.cn/2019/07/12232327834639.shtml",
    "datetime": "2019-07-12 23:23:51",
    "code": "300006"
  },
  {
    "title": "莱美药业增收不增利 实控人寻求脱困拟引国资纾困",
    "href": "http://stock.jrj.com.cn/2019/07/10083027819968.shtml",
    "datetime": "2019-07-10 08:30:38",
    "code": "300006"
  },
  {
    "title": "莱美药业引入国有战略投资者 公司控制权或将发生变化",
    "href": "http://stock.jrj.com.cn/invest/2019/07/09083127815133.shtml",
    "datetime": "2019-07-09 08:31:00",
    "code": "300006"
  },
  {
    "title": "莱美药业拟引入国资 实控人或变更为南岸城建",
    "href": "http://stock.jrj.com.cn/2019/07/09080227814966.shtml",
    "datetime": "2019-07-09 08:02:37",
    "code": "300006"
  },
  {
    "title": "莱美药业控股股东签署战略合作意向协议 实控人拟发生变更",
    "href": "http://stock.jrj.com.cn/2019/07/08202527810811.shtml",
    "datetime": "2019-07-08 20:25:04",
    "code": "300006"
  },
  {
    "title": "莱美药业：拟引入国有战投 实控人或将变更为南岸城建",
    "href": "http://stock.jrj.com.cn/2019/07/08201227810783.shtml",
    "datetime": "2019-07-08 20:12:00",
    "code": "300006"
  },
  {
    "title": "莱美药业处置完毕Athenex公司股票 预计增利900余万元",
    "href": "http://stock.jrj.com.cn/2019/06/28201627771055.shtml",
    "datetime": "2019-06-28 20:16:22",
    "code": "300006"
  },
  {
    "title": "莱美药业股东邱炜拟减持股份 预计减持不超总股本1%",
    "href": "http://stock.jrj.com.cn/2019/06/19074227722975.shtml",
    "datetime": "2019-06-19 07:42:13",
    "code": "300006"
  },
  {
    "title": "莱美药业：股东邱炜拟减持不超1%股份",
    "href": "http://stock.jrj.com.cn/2019/06/18170127720452.shtml",
    "datetime": "2019-06-18 17:01:00",
    "code": "300006"
  },
  {
    "title": "莱美药业：持股6.52%的股东拟减持不超1%",
    "href": "http://stock.jrj.com.cn/2019/06/18165327720383.shtml",
    "datetime": "2019-06-18 16:53:43",
    "code": "300006"
  },
  {
    "title": "莱美药业携手爱尔眼科搭建眼科产品平台",
    "href": "http://stock.jrj.com.cn/2019/05/07205627538886.shtml",
    "datetime": "2019-05-07 20:56:35",
    "code": "300006"
  },
  {
    "title": "[莱美药业]莱美药业:中国医药自主研发先行者",
    "href": "http://stock.jrj.com.cn/2019/05/07000027704379.shtml",
    "datetime": "2019-05-07 00:00:00",
    "code": "300006"
  },
  {
    "title": "莱美药业：“二代伟哥”4月开始上市推广",
    "href": "http://stock.jrj.com.cn/2019/04/24225527477522.shtml",
    "datetime": "2019-04-24 22:55:05",
    "code": "300006"
  },
  {
    "title": "莱美药业副总经理赵斌计划减持股份 公司一季度净利下滑超45%",
    "href": "http://stock.jrj.com.cn/2019/04/22152927454065.shtml",
    "datetime": "2019-04-22 15:29:20",
    "code": "300006"
  },
  {
    "title": "莱美药业：股东拟减持不超过20万股 占比0.024％",
    "href": "http://stock.jrj.com.cn/2019/04/19182327429694.shtml",
    "datetime": "2019-04-19 18:23:15",
    "code": "300006"
  },
  {
    "title": "莱美药业一季度扣非后净利润同比上升",
    "href": "http://stock.jrj.com.cn/2019/04/09195927358229.shtml",
    "datetime": "2019-04-09 19:59:46",
    "code": "300006"
  },
  {
    "title": "莱美药业：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/04/09193027355663.shtml",
    "datetime": "2019-04-09 19:30:00",
    "code": "300006"
  },
  {
    "title": "莱美药业获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/02/25184827085463.shtml",
    "datetime": "2019-02-25 18:48:16",
    "code": "300006"
  },
  {
    "title": "莱美药业：获得GMP证书",
    "href": "http://stock.jrj.com.cn/2019/02/25174027085154.shtml",
    "datetime": "2019-02-25 17:40:00",
    "code": "300006"
  },
  {
    "title": "莱美药业获首款国产仿制 ED治疗药物独家代理权",
    "href": "http://stock.jrj.com.cn/2019/02/20002627064169.shtml",
    "datetime": "2019-02-20 00:26:45",
    "code": "300006"
  },
  {
    "title": "莱美药业新药上市尚需时日 股价三年跌去八成",
    "href": "http://stock.jrj.com.cn/2019/01/17020626916085.shtml",
    "datetime": "2019-01-17 02:06:47",
    "code": "300006"
  },
  {
    "title": "莱美药业：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/09213026881402.shtml",
    "datetime": "2019-01-09 21:30:00",
    "code": "300006"
  },
  {
    "title": "莱美药业：2018年净利预增98%-125%",
    "href": "http://stock.jrj.com.cn/2019/01/09205726881268.shtml",
    "datetime": "2019-01-09 20:57:01",
    "code": "300006"
  },
  {
    "title": "[莱美药业]“莱美舒”荣获中国产学研合作创新成果优秀奖",
    "href": "http://stock.jrj.com.cn/2019/01/08000027704375.shtml",
    "datetime": "2019-01-08 00:00:00",
    "code": "300006"
  },
  {
    "title": "莱美药业：目前未受带量采购影响 将加大专科药销售力度",
    "href": "http://stock.jrj.com.cn/2018/12/13165126735489.shtml",
    "datetime": "2018-12-13 16:51:00",
    "code": "300006"
  },
  {
    "title": "[莱美药业]莱美一实验室获2018重庆市工业和信息化重点实验室认定",
    "href": "http://stock.jrj.com.cn/2018/11/14000027704374.shtml",
    "datetime": "2018-11-14 00:00:00",
    "code": "300006"
  },
  {
    "title": "[莱美药业]深交所莅临我司进行调研",
    "href": "http://stock.jrj.com.cn/2018/11/07000027704376.shtml",
    "datetime": "2018-11-07 00:00:00",
    "code": "300006"
  },
  {
    "title": "[莱美药业]全球领先----卡纳琳入选国家制造业单项冠军产品公示名单",
    "href": "http://stock.jrj.com.cn/2018/11/07000027704377.shtml",
    "datetime": "2018-11-07 00:00:00",
    "code": "300006"
  },
  {
    "title": "莱美药业前三季度净利润同比增长64%",
    "href": "http://stock.jrj.com.cn/2018/10/19180725229258.shtml",
    "datetime": "2018-10-19 18:07:12",
    "code": "300006"
  },
  {
    "title": "莱美药业前三季度净利润预增64%-72%",
    "href": "http://stock.jrj.com.cn/2018/10/12184925197031.shtml",
    "datetime": "2018-10-12 18:49:45",
    "code": "300006"
  },
  {
    "title": "莱美药业：上半年净利8076万元 同比增长86%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/27091425003306.shtml",
    "datetime": "2018-08-27 09:14:21",
    "code": "300006"
  },
  {
    "title": "莱美药业上半年净利润同比增长86%",
    "href": "http://stock.jrj.com.cn/2018/08/24214224998743.shtml",
    "datetime": "2018-08-24 21:42:42",
    "code": "300006"
  },
  {
    "title": "莱美药业董事长哥哥违规减持 遭重庆证监局约谈",
    "href": "http://stock.jrj.com.cn/2018/07/20203124844496.shtml",
    "datetime": "2018-07-20 20:31:45",
    "code": "300006"
  },
  {
    "title": "莱美药业：上半年净利预增91%-103%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/07/11080024797905.shtml",
    "datetime": "2018-07-11 08:00:03",
    "code": "300006"
  },
  {
    "title": "莱美药业：上半年净利预增91%至102%",
    "href": "http://stock.jrj.com.cn/2018/07/10200524796421.shtml",
    "datetime": "2018-07-10 20:05:00",
    "code": "300006"
  },
  {
    "title": "莱美药业半年报净利润预增91%-103%",
    "href": "http://stock.jrj.com.cn/2018/07/10184524796104.shtml",
    "datetime": "2018-07-10 18:45:54",
    "code": "300006"
  },
  {
    "title": "莱美药业：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/07/10180024795932.shtml",
    "datetime": "2018-07-10 18:00:00",
    "code": "300006"
  },
  {
    "title": "[莱美药业]重庆莱美药业股份有限公司 环境信息公开表",
    "href": "http://stock.jrj.com.cn/2018/06/14000027704373.shtml",
    "datetime": "2018-06-14 00:00:00",
    "code": "300006"
  },
  {
    "title": "莱美药业拟出资6亿再设产业投资基金",
    "href": "http://stock.jrj.com.cn/2018/06/05212724640976.shtml",
    "datetime": "2018-06-05 21:27:25",
    "code": "300006"
  },
  {
    "title": "莱美药业持股5%以上股东提前终止减持计划",
    "href": "http://stock.jrj.com.cn/2018/06/04201324635566.shtml",
    "datetime": "2018-06-04 20:13:00",
    "code": "300006"
  },
  {
    "title": "莱美药业股东减持1310万股",
    "href": "http://stock.jrj.com.cn/2018/05/31203124620502.shtml",
    "datetime": "2018-05-31 20:31:00",
    "code": "300006"
  },
  {
    "title": "莱美药业：股东邱炜累计减持5.97%股份",
    "href": "http://stock.jrj.com.cn/2018/05/31203024620488.shtml",
    "datetime": "2018-05-31 20:30:00",
    "code": "300006"
  },
  {
    "title": "[莱美药业]公司技术中心荣获“全国工人先锋号”",
    "href": "http://stock.jrj.com.cn/2018/05/20000027704378.shtml",
    "datetime": "2018-05-20 00:00:00",
    "code": "300006"
  },
  {
    "title": "莱美药业今年将产融结合谋发展",
    "href": "http://stock.jrj.com.cn/2018/04/22180824428042.shtml",
    "datetime": "2018-04-22 18:08:41",
    "code": "300006"
  },
  {
    "title": "莱美药业一季度业绩预计翻番",
    "href": "http://stock.jrj.com.cn/2018/04/09211224364355.shtml",
    "datetime": "2018-04-09 21:12:09",
    "code": "300006"
  },
  {
    "title": "莱美药业：2018年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/09203024364169.shtml",
    "datetime": "2018-04-09 20:30:00",
    "code": "300006"
  },
  {
    "title": "莱美药业一季度业绩预增96%-114%",
    "href": "http://stock.jrj.com.cn/2018/04/09185924363780.shtml",
    "datetime": "2018-04-09 18:59:37",
    "code": "300006"
  },
  {
    "title": "崔丹担任莱美药业董事会秘书",
    "href": "http://stock.jrj.com.cn/2018/03/27175924307307.shtml",
    "datetime": "2018-03-27 17:59:00",
    "code": "300006"
  },
  {
    "title": "莱美药业2017年度净利润同比增逾8倍",
    "href": "http://stock.jrj.com.cn/2018/02/27185324162126.shtml",
    "datetime": "2018-02-27 18:53:05",
    "code": "300006"
  },
  {
    "title": "莱美药业业绩快报：2017年净利增逾8倍",
    "href": "http://stock.jrj.com.cn/2018/02/27183024162009.shtml",
    "datetime": "2018-02-27 18:30:00",
    "code": "300006"
  },
  {
    "title": "莱美药业携泸州老窖共设产业并购基金",
    "href": "http://stock.jrj.com.cn/2018/02/26215424155984.shtml",
    "datetime": "2018-02-26 21:54:43",
    "code": "300006"
  },
  {
    "title": "莱美药业2017年预盈约6600万 同比大增逾8倍",
    "href": "http://stock.jrj.com.cn/2018/01/30222424033675.shtml",
    "datetime": "2018-01-30 22:24:15",
    "code": "300006"
  },
  {
    "title": "莱美药业持股5%以上股东计划减持4061万股",
    "href": "http://stock.jrj.com.cn/2017/12/06201923752125.shtml",
    "datetime": "2017-12-06 20:19:00",
    "code": "300006"
  },
  {
    "title": "莱美药业：股东邱炜拟减持不超过5%股份",
    "href": "http://stock.jrj.com.cn/2017/12/06183423751641.shtml",
    "datetime": "2017-12-06 18:34:07",
    "code": "300006"
  },
  {
    "title": "[莱美药业]公司作为股东参与中国生物医药知识产权国际运营平台揭牌",
    "href": "http://stock.jrj.com.cn/2017/12/04000023738385.shtml",
    "datetime": "2017-12-04 00:00:00",
    "code": "300006"
  },
  {
    "title": "莱美药业：拟2.49亿元参与发起设立产业并购基金",
    "href": "http://stock.jrj.com.cn/hotstock/2017/12/01075923724893.shtml",
    "datetime": "2017-12-01 07:59:57",
    "code": "300006"
  },
  {
    "title": "莱美药业投资设立产业并购基金",
    "href": "http://stock.jrj.com.cn/2017/11/30205523723056.shtml",
    "datetime": "2017-11-30 20:55:42",
    "code": "300006"
  },
  {
    "title": "莱美药业：斥资2.49亿元参与发起设立产业并购基金",
    "href": "http://stock.jrj.com.cn/2017/11/30184023722415.shtml",
    "datetime": "2017-11-30 18:40:00",
    "code": "300006"
  },
  {
    "title": "莱美药业近日收到政府补贴30万元",
    "href": "http://stock.jrj.com.cn/2017/11/30180023722050.shtml",
    "datetime": "2017-11-30 18:00:18",
    "code": "300006"
  },
  {
    "title": "[莱美药业]第三届研医会甲状腺高峰论坛暨术后管理智能服务专业组大会圆满召开",
    "href": "http://stock.jrj.com.cn/2017/08/30000023034322.shtml",
    "datetime": "2017-08-30 00:00:00",
    "code": "300006"
  },
  {
    "title": "莱美药业上半年盈利增逾34%",
    "href": "http://stock.jrj.com.cn/2017/08/24230622996997.shtml",
    "datetime": "2017-08-24 23:06:00",
    "code": "300006"
  },
  {
    "title": "[哈药股份]莱美药业业绩变脸股价大跌 员工持股计划精准清仓完美躲过了这一劫",
    "href": "http://stock.jrj.com.cn/2017/04/01000024834733.shtml",
    "datetime": "2017-04-01 00:00:00",
    "code": "300006"
  },
  {
    "title": "[哈药股份]莱美药业业绩变脸股价大跌 员工持股计划精准清仓完美躲过了这一劫",
    "href": "http://stock.jrj.com.cn/2017/04/01000031006470.shtml",
    "datetime": "2017-04-01 00:00:00",
    "code": "300006"
  },
  {
    "title": "AGS-003效果遭质疑 莱美药业中枪计提减值准备",
    "href": "http://stock.jrj.com.cn/2017/03/31014122248165.shtml",
    "datetime": "2017-03-31 01:41:23",
    "code": "300006"
  },
  {
    "title": "[哈药股份]莱美药业业绩变脸股价大跌",
    "href": "http://stock.jrj.com.cn/2017/03/31000024834728.shtml",
    "datetime": "2017-03-31 00:00:00",
    "code": "300006"
  },
  {
    "title": "[哈药股份]莱美药业业绩变脸股价大跌",
    "href": "http://stock.jrj.com.cn/2017/03/31000031006461.shtml",
    "datetime": "2017-03-31 00:00:00",
    "code": "300006"
  },
  {
    "title": "莱美药业拟出资1246万参设医药科技合伙企业",
    "href": "http://stock.jrj.com.cn/2017/01/18065021980078.shtml",
    "datetime": "2017-01-18 06:50:02",
    "code": "300006"
  },
  {
    "title": "莱美药业：甲磺酸伊马替尼片获得药物临床试验批件",
    "href": "http://stock.jrj.com.cn/hotstock/2016/11/04075921663818.shtml",
    "datetime": "2016-11-04 07:59:58",
    "code": "300006"
  },
  {
    "title": "[互动]莱美药业埃索美拉挫肠溶胶囊在多省市中标",
    "href": "http://stock.jrj.com.cn/2016/08/23150721357045.shtml",
    "datetime": "2016-08-23 15:07:01",
    "code": "300006"
  },
  {
    "title": "莱美药业被美国食药监局出具警告信",
    "href": "http://stock.jrj.com.cn/2016/06/30183121136606.shtml",
    "datetime": "2016-06-30 18:31:00",
    "code": "300006"
  },
  {
    "title": "上市公司年报高送转预案：天齐锂业拟10转28派3",
    "href": "http://stock.jrj.com.cn/2016/04/22235220870144.shtml",
    "datetime": "2016-04-22 23:52:06",
    "code": "300006"
  },
  {
    "title": "莱美药业：推出10转26预案 股价有望继续震荡上扬",
    "href": "http://stock.jrj.com.cn/2016/02/23225220597962.shtml",
    "datetime": "2016-02-23 22:52:13",
    "code": "300006"
  },
  {
    "title": "莱美药业：公司实际控制人承诺六个月内不减持公告",
    "href": "http://stock.jrj.com.cn/2016/01/14144420414383.shtml",
    "datetime": "2016-01-14 14:44:51",
    "code": "300006"
  },
  {
    "title": "莱美药业：拟对全资子公司莱美香港增资9900万美元",
    "href": "http://stock.jrj.com.cn/hotstock/2015/03/20075918990738.shtml",
    "datetime": "2015-03-20 07:59:47",
    "code": "300006"
  },
  {
    "title": "A股年报披露启动莱美药业成渝股首家",
    "href": "http://stock.jrj.com.cn/2015/01/05075518643966.shtml",
    "datetime": "2015-01-05 07:55:40",
    "code": "300006"
  },
  {
    "title": "莱美药业控股子公司通过新版GMP审核",
    "href": "http://stock.jrj.com.cn/2014/09/11123117986633.shtml",
    "datetime": "2014-09-11 12:31:33",
    "code": "300006"
  },
  {
    "title": "两大产品上市在即 莱美药业将迎业绩拐点",
    "href": "http://stock.jrj.com.cn/2014/06/10065817371616.shtml",
    "datetime": "2014-06-10 06:58:00",
    "code": "300006"
  },
  {
    "title": "莱美药业替莫唑胺原料药获美国FDA认证",
    "href": "http://stock.jrj.com.cn/2014/01/03050916440258.shtml",
    "datetime": "2014-01-03 05:09:17",
    "code": "300006"
  },
  {
    "title": "莱美药业股东重庆风投累计减持1.82%股份",
    "href": "http://stock.jrj.com.cn/2013/12/12120516319323.shtml",
    "datetime": "2013-12-12 12:05:00",
    "code": "300006"
  },
  {
    "title": "渝三峡A和莱美药业上半年实现业绩增长",
    "href": "http://stock.jrj.com.cn/2013/08/26102015737579.shtml",
    "datetime": "2013-08-26 10:20:26",
    "code": "300006"
  },
  {
    "title": "新产品存想象空间 莱美药业创历史新高",
    "href": "http://stock.jrj.com.cn/hotstock/2013/08/15052615686548.shtml",
    "datetime": "2013-08-15 05:26:49",
    "code": "300006"
  },
  {
    "title": "莱美药业增发回购IPO募投项目公司",
    "href": "http://stock.jrj.com.cn/2013/06/06053915375134.shtml",
    "datetime": "2013-06-06 05:39:29",
    "code": "300006"
  },
  {
    "title": "拟增资控股金星公司 莱美药业挺进生物制药",
    "href": "http://stock.jrj.com.cn/2013/05/09070215287230.shtml",
    "datetime": "2013-05-09 07:02:31",
    "code": "300006"
  },
  {
    "title": "莱美药业将向金星药业增资2亿元",
    "href": "http://stock.jrj.com.cn/2013/05/08215115286597.shtml",
    "datetime": "2013-05-08 21:51:06",
    "code": "300006"
  },
  {
    "title": "上市公司曲线融资开先例 莱美药业借道子公司融资3.4亿",
    "href": "http://stock.jrj.com.cn/2013/03/15142115146463.shtml",
    "datetime": "2013-03-15 14:21:49",
    "code": "300006"
  },
  {
    "title": "莱美药业股东减持420万股",
    "href": "http://stock.jrj.com.cn/2012/11/21071914706886.shtml",
    "datetime": "2012-11-21 07:19:47",
    "code": "300006"
  },
  {
    "title": "莱美药业遭股东减持",
    "href": "http://stock.jrj.com.cn/2012/11/12022414656487.shtml",
    "datetime": "2012-11-12 02:24:56",
    "code": "300006"
  },
  {
    "title": "莱美药业：资金紧张致募投项目延期",
    "href": "http://stock.jrj.com.cn/2012/09/17102514399583.shtml",
    "datetime": "2012-09-17 10:25:12",
    "code": "300006"
  },
  {
    "title": "莱美药业：看好前景发展 “买入”评级",
    "href": "http://stock.jrj.com.cn/hotstock/2012/08/28083914283897.shtml",
    "datetime": "2012-08-28 08:39:41",
    "code": "300006"
  },
  {
    "title": "莱美药业：2011年业绩预增110%",
    "href": "http://stock.jrj.com.cn/2012/01/31085812132498.shtml",
    "datetime": "2012-01-31 08:58:52",
    "code": "300006"
  },
  {
    "title": "莱美药业重组4天流产 做大做强计划止步不前",
    "href": "http://stock.jrj.com.cn/2011/12/30080911945715.shtml",
    "datetime": "2011-12-30 08:09:12",
    "code": "300006"
  },
  {
    "title": "莱美药业预计净利增80%-130%",
    "href": "http://stock.jrj.com.cn/2011/07/14145710448270.shtml",
    "datetime": "2011-07-14 14:57:02",
    "code": "300006"
  },
  {
    "title": "2日创业板莱美药业大宗交易6600万元",
    "href": "http://stock.jrj.com.cn/2011/03/0314309350592.shtml",
    "datetime": "2011-03-03 14:30:06",
    "code": "300006"
  },
  {
    "title": "莱美药业：拟携重庆风投收购禾正制药",
    "href": "http://stock.jrj.com.cn/2011/02/1102519160251.shtml",
    "datetime": "2011-02-11 02:51:40",
    "code": "300006"
  },
  {
    "title": "莱美药业：开市起临时停牌",
    "href": "http://stock.jrj.com.cn/2010/12/0809098733719.shtml",
    "datetime": "2010-12-08 09:09:59",
    "code": "300006"
  },
  {
    "title": "青海明胶：拟向莱美药业转让子公司 明起停牌",
    "href": "http://stock.jrj.com.cn/2010/12/0721048730683.shtml",
    "datetime": "2010-12-07 21:04:26",
    "code": "300006"
  }
]